Clinical Research Details Clinical Research MBPS205: A Phase 2b, Multicentre, Multinational, Placebo-controlled, Double-blind, Dose-finding Study in Adult Patients with Type I, III or IV Osteogenesis Imperfecta Treated with BPS804 Study Description The purpose of this study is to learn about the effects of a research drug, BPS804, to find the best dose for treating osteogenesis imperfecta Type I, III or IV and to see how well BPS804 is tolerated. Investigators